Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy – PubMed
The most robust evidence for the use of CAC scoring is in select individuals, 40-75 years of age, at borderline to intermediate 10-year ASCVD risk. Recent US recommendations support the use of CAC scoring in varying clinical scenarios. First, in adults with very high CAC scores (CAC ≥ 1000), the use …